Corvus Pharmaceuticals Provides Business Update and Reports
Soquelitinib Phase 1 Randomized Trial in Atopic Dermatitis Enrolling at Multiple Centers; Potential for Early Data Before Year-End 2024 Soquelitinib...
Source: globenewswire.com
📰 Partner Led Program News
Partner Led Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Partner Led Program. Real-time updates on events, politics, business and more.